What is the current Infection Control Surveillance Solution market size?

The Infection Control Surveillance Solution market size was valued at USD 1.2 billion in 2023, projected to grow significantly due to rising healthcare-associated infections and digital adoption.

What is the future outlook for market growth?

The future outlook is optimistic, with a CAGR of 6.5% expected from 2024 to 2031, driven by AI integration and post-pandemic healthcare reforms.

What are the key growth drivers?

Key drivers include regulatory mandates, AI/ML innovations, and the need to reduce hospital-acquired infections globally.

What challenges hinder market expansion?

High implementation costs, interoperability issues, and resistance to data sharing impede widespread adoption.

Which regions are leading the market?

North America leads in adoption, while Asia-Pacific is the fastest-growing region due to expanding healthcare infrastructure and government funding.

Who are the top companies in this market?

Leading firms include BD, Philips, 3M, and Cerner, focusing on AI-driven solutions and strategic partnerships to enhance market reach.

What future opportunities exist for this market?

Opportunities include telehealth integration, wearable technology for real-time monitoring, and expanding applications in outpatient care settings.

How is technology reshaping this industry?

AI, IoT, and big data analytics are enabling predictive surveillance, automating infection tracking, and improving outbreak response efficiency.

What is the regulatory landscape like?

Regulatory bodies like the FDA and WHO enforce strict infection control standards, driving compliance and innovation in surveillance systems.

Global Infection Control Surveillance Solution Market Value Is Forecast To Reach By 2034 With CAGR

Infection Control Surveillance Solution by Application (Hospital, Clinic, Others), by Type (Software, Service), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Infection Control Surveillance Solution Market Size | CAGR 14.2 Forecast 2033

Global Infection Control Surveillance Solution Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 14.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Infection Control Surveillance Solution Market Overview

The Infection Control Surveillance Solution market encompasses technologies and systems designed to monitor, analyze, and mitigate healthcare-associated infections (HAIs) in clinical and non-clinical settings. These solutions are critical for reducing infection risks, improving patient outcomes, and ensuring compliance with global health regulations. Infection Control Surveillance Solution market size is projected to reflect robust growth outlook through 2033, driven by rising HAI incidence, digital healthcare adoption, and regulatory mandates. This report analyzes the market forecast from 2021–2033, with a base year of 2025 and forecast period spanning 2026–2033, focusing on technologies, applications, and regional dynamics shaping industry expansion.

Loading chart…

The Infection Control Surveillance Solution market is estimated at USD 1.4 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.5% from 2026–2033. Key drivers include AI/ML integration for real-time surveillance, stringent HACCP and JCI compliance requirements, and rising hospitalization rates. North America leads the market due to advanced healthcare IT infrastructure, while Asia-Pacific emerges as the fastest-growing region, fueled by government investments in public health systems. Strategic partnerships between tech firms and healthcare providers will further accelerate industry expansion, despite challenges such as high implementation costs and data privacy concerns.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	3.62 billion
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter International Inc; Premier Inc.; Cerner Corporation; Becton; Dickinson and Company; GOJo Industries, lnc.; Sunquest; BMCorporation; OASIS Medical; Ecolab lnc.; Harris Healthcare; CenTrak, Inc.; Roper Technologies.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of healthcare-associated infections (HAIs) is intensifying demand for Infection Control Surveillance Solution market adoption. Hospitals and long-term care facilities are prioritizing real-time monitoring tools to reduce HAI rates, driven by regulatory mandates such as CDC guidelines and Joint Commission standards.

Advancements in AI and machine learning are enabling predictive analytics in Infection Control Surveillance Solution market size growth. These technologies enhance early outbreak detection and streamline compliance reporting, creating a competitive edge for providers seeking to improve patient safety and operational efficiency.

Restraints2 items

High initial implementation costs, including software licensing, staff training, and integration with existing EMR/EHR systems, hinder market penetration, particularly in resource-constrained healthcare settings.

Interoperability challenges persist due to fragmented IT infrastructure, delaying adoption in facilities relying on legacy systems incompatible with newer surveillance platforms.

Opportunities2 items

Expansion into emerging markets, such as Asia-Pacific and Latin America, where rising healthcare expenditure and government investments in hospital modernization are accelerating Infection Control Surveillance Solution market growth.

Integration with telehealth platforms and IoT-enabled devices presents a strategic growth avenue, aligning with the shift toward remote patient monitoring and decentralized care models.

Challenges2 items

Stringent data privacy regulations, including HIPAA and GDPR, impose compliance burdens, increasing operational costs and complexity for global market players.

Price sensitivity among end-users, coupled with intense competition from regional players, is compressing profit margins and necessitating continuous innovation to maintain market share.

Market Segmentation

Loading chart…

Application Segmentation in the Infection Control Surveillance Solution market is critical to understanding demand drivers. The primary segments include Hospitals, Long-Term Care Facilities (LTCF), Diagnostic & Testing Laboratories, and Public Health Agencies. Hospitals dominate the market due to high rates of healthcare-associated infections (HAIs) and stringent regulatory requirements for real-time monitoring. LTCF accounts for a significant share due to the elderly population’s vulnerability to outbreaks. Diagnostic laboratories rely on rapid detection systems for pathogen identification, while public health agencies prioritize outbreak tracking. This segmentation underscores how application-specific needs shape the Infection Control Surveillance Solution market size, with hospitals and LTCF collectively representing over 60% of revenue.

Type Segmentation divides the market into Software Solutions and Hardware & Devices. Software solutions, including AI-driven analytics and cloud-based platforms, dominate adoption due to scalability and integration with existing EMR systems. Hardware components such as biosensors, UV disinfection robots, and IoT-enabled temperature monitors form the second pillar, driven by technological advancements. The software segment constitutes ~55% of the market, reflecting its role in data aggregation and predictive modeling. Hardware adoption is rising in acute care settings where physical monitoring is essential. This market taxonomy highlights complementary roles: software enables actionable insights, while hardware ensures on-the-ground implementation, collectively defining the Infection Control Surveillance Solution market’s growth trajectory.

Infection Control Surveillance Solution Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Type

Software

Service

Regional Insights

Loading chart…

North America dominates the Infection Control Surveillance Solution market with a 35% share, driven by advanced healthcare infrastructure, stringent regulatory frameworks like CMS requirements, and high adoption of AI-driven solutions. The region’s aging population and rising hospital-acquired infection (HAI) rates further accelerate demand. Europe follows with a 28% share, fueled by EU-funded initiatives such as the European Programme for Infection Control (EPIC) and growing antibiotic resistance concerns. Germany and the UK lead in digital twin adoption for predictive analytics.

The Asia Pacific region is the fastest-growing, expanding at a CAGR of 14%, supported by government investments (e.g., India’s Ayushman Bharat) and urbanization. China and Japan prioritize IoT-enabled surveillance systems, while Southeast Asia adopts low-cost solutions. Latin America (9% share) lags due to fragmented healthcare systems but shows potential through PPPs and telemedicine integration. The Middle East & Africa (6% share) faces infrastructure gaps but benefits from smart hospital projects in the Gulf and WHO-backed initiatives.

Regional forecast insights highlight ecosystem maturity as a key differentiator. North America’s $2.1B investments in 2023 underscore its leadership, while Asia Pacific’s demographic pressures and pandemic preparedness drive innovation. Europe’s mature regulatory environment ensures steady growth, contrasting with Latin America’s reliance on donor-funded programs. Strategic partnerships and AI integration will define the Infection Control Surveillance Solution market growth trajectory across regions.

Competitive Landscape

The Infection Control Surveillance Solution market is moderately consolidated, with a mix of global players and regional specialists. The Infection Control Surveillance Solution competitive landscape is shaped by product differentiation through advanced analytics, integration with hospital IT systems, and compliance with regulatory standards such as JCAHO and HIPAA. Pricing remains a critical lever, particularly in price-sensitive markets, while partnerships with healthcare providers and OEM agreements with medical device manufacturers drive distribution. Key players emphasize innovation in real-time monitoring and AI-driven predictive analytics to maintain a performance edge, though the market remains fragmented in emerging economies due to localized regulatory hurdles and infrastructure gaps.

Strategic priorities include vertical integration, cross-sector partnerships, and geographic expansion to capture emerging markets. Competitive differentiation hinges on proprietary technology, such as machine learning algorithms for outbreak prediction, and scalable service models tailored to acute care and long-term facilities. A key challenge is balancing compliance costs with margin pressures, exacerbated by frequent updates to infection control regulations. Companies are also addressing supply chain risks by localizing manufacturing and diversifying supplier bases, though this increases operational complexity for smaller firms.

Baxter International Inc: OEM tie-ups to enhance hospital integration.

Premier Inc.: Data analytics partnerships for healthcare networks.

Cerner Corporation: Vertical integration with EHR systems for surveillance.

Becton, Dickinson and Company: R&D focus on point-of-care sterilization solutions.

Ecolab Inc.: Regional expansion via localized product customization.

Roper Technologies: Acquisitions to strengthen infection tracking portfolios.

Key Infection Control Surveillance Solution Companies13 items

Baxter International Inc

Premier Inc.

Cerner Corporation

Becton

Dickinson and Company

GOJo Industries, lnc.

Sunquest

BMCorporation

OASIS Medical

Ecolab lnc.

Harris Healthcare

CenTrak, Inc.

Roper Technologies.

Market Ecosystem

The Infection Control Surveillance Solution ecosystem spans upstream technology development, midstream integration, and downstream deployment. Value is generated through the convergence of hardware, software, and data analytics to monitor, track, and mitigate healthcare-associated infections. Suppliers and integrators collaborate to tailor solutions for end-user environments, while regulatory frameworks shape compliance requirements across the value chain analysis.

Component suppliers — provide sensors, IoT devices, and software modules for surveillance systems

Technology providers — develop core AI/ML algorithms and data platforms for infection tracking

System integrators — configure end-to-end solutions by combining hardware, software, and clinical workflows

Distributors — manage logistics and sales channels for solution deployment in healthcare facilities

Healthcare facilities — implement surveillance systems for real-time infection monitoring and reporting

Service providers — offer training, maintenance, and software updates for sustained system performance

Regulatory bodies — establish certification standards and audit compliance for infection control protocols

Control points reside with regulators, whose approvals dictate market entry, and integrators, who bridge technical capabilities with clinical needs. Dependency risks include supply chain disruptions for critical components and interoperability challenges across legacy systems. High customization demands in healthcare settings increase switching costs, reinforcing long-term partnerships between solution providers and end users.

Recent Industry Insights

Infection Control Surveillance Solution industry trends have seen rapid evolution over the past 18 months, driven by advancements in AI-powered analytics, heightened regulatory scrutiny, and surging demand for real-time monitoring. Key developments include strategic partnerships between surveillance solution providers and hospital networks to integrate IoT-enabled devices for data-driven infection tracking. Mergers & acquisitions have accelerated, with major players acquiring niche startups specializing in predictive analytics to strengthen their offerings. Product launches highlight innovations like cloud-based platforms with machine learning capabilities, enabling early outbreak detection. Regulatory changes, such as updated FDA guidelines for digital surveillance tools, have pushed companies to prioritize interoperability and cybersecurity. Enterprise trends reflect a shift toward AI-driven automation to reduce manual reporting burdens, while consumer demand for wearable infection monitoring devices has grown in healthcare settings. Funding rounds have surged, with Series B investments targeting scalable solutions for low-resource hospitals, signaling a forward-looking industry poised for global expansion.

Analyst Overview

Market attractiveness remains high due to rising healthcare-associated infection (HAI) prevalence and stringent regulatory mandates. The Infection Control Surveillance Solution market outlook is further bolstered by digital transformation in healthcare, driving demand for real-time monitoring systems.

Competitive intensity is moderate, with established players dominating the premium segment and niche startups innovating in AI-driven analytics. Consolidation is expected as smaller firms seek partnerships to enhance data integration capabilities.

Long-term outlook is optimistic, supported by aging populations and hospital infrastructure expansion in emerging economies. However, adoption rates will hinge on ROI visibility for acute care facilities.

Innovation landscape highlights3 items

AI-powered predictive analytics gaining traction

IoMT-enabled devices reducing manual data entry errors

Cloud-based platforms improving cross-facility collaboration

Demand–supply balance shows growing demand outpacing supply in low-resource regions, creating opportunities for scalable, cost-effective solutions. Premium segments face oversupply due to saturated offerings.

Key risk factors3 items

Regulatory shifts impacting reimbursement models

Interoperability challenges with legacy EHR systems

Cybersecurity vulnerabilities in connected devices

11 items

1. Executive Summary

2. Infection Control Surveillance Solution Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Infection Control Surveillance Solution Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Infection Control Surveillance Solution Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Infection Control Surveillance Solution Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. Software

6.2.2. Service

6.3. Global Infection Control Surveillance Solution Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Infection Control Surveillance Solution Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Infection Control Surveillance Solution Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Infection Control Surveillance Solution Market Competition by Key Manufacturers

8.1. Global Infection Control Surveillance Solution Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Infection Control Surveillance Solution: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Baxter International Inc

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Premier Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cerner Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Becton

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Dickinson and Company

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. GOJo Industries, lnc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Sunquest

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BMCorporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. OASIS Medical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Ecolab lnc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Harris Healthcare

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CenTrak, Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Roper Technologies.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Infection Control Surveillance Solution Market

Figure 4: Global Infection Control Surveillance Solution Market: Drivers

Figure 5: Global Infection Control Surveillance Solution Market: Challenges

Figure 6: Global Infection Control Surveillance Solution Market: Trends

Figure 7: Global Infection Control Surveillance Solution Market: Opportunity

Figure 8: Global Infection Control Surveillance Solution Market: Restraint

Figure 9: Global Infection Control Surveillance Solution Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Infection Control Surveillance Solution Market Value (USD Million) By Region

Figure 15: Global Infection Control Surveillance Solution Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Infection Control Surveillance Solution Market Value (USD Million) By Region

Figure 23: Global Infection Control Surveillance Solution Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Infection Control Surveillance Solution Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Infection Control Surveillance Solution Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Infection Control Surveillance Solution Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Infection Control Surveillance Solution Market Value (USD Million) By Region

Table 10: Global Infection Control Surveillance Solution Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Infection Control Surveillance Solution Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Infection Control Surveillance Solution Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Infection Control Surveillance Solution Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Baxter International Inc Basic Information And Sales Area

Table 31: Baxter International Inc. Products Portfolio

Table 32: Premier Inc. Basic Information And Sales Area

Table 33: Premier Inc.. Products Portfolio

Table 34: Cerner Corporation Basic Information And Sales Area

Table 35: Cerner Corporation. Products Portfolio

Table 36: Becton Basic Information And Sales Area

Table 37: Becton. Products Portfolio

Table 38: Dickinson and Company Basic Information And Sales Area

Table 39: Dickinson and Company. Products Portfolio

Table 40: GOJo Industries, lnc. Basic Information And Sales Area

Table 41: GOJo Industries, lnc.. Products Portfolio

Table 42: Sunquest Basic Information And Sales Area

Table 43: Sunquest. Products Portfolio

Table 44: BMCorporation Basic Information And Sales Area

Table 45: BMCorporation. Products Portfolio

Table 46: OASIS Medical Basic Information And Sales Area

Table 47: OASIS Medical. Products Portfolio

Table 48: Ecolab lnc. Basic Information And Sales Area

Table 49: Ecolab lnc.. Products Portfolio

Table 50: Harris Healthcare Basic Information And Sales Area

Table 51: Harris Healthcare. Products Portfolio

Table 52: CenTrak, Inc. Basic Information And Sales Area

Table 53: CenTrak, Inc.. Products Portfolio

Table 54: Roper Technologies. Basic Information And Sales Area

Table 55: Roper Technologies.. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Type

Table 59: Global Market Share (%) By Type (2032)

Table 60: Global Infection Control Surveillance Solution Market Value (USD Million) By Region

Table 61: Global Infection Control Surveillance Solution Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Type

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Type

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Type

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Infection Control Surveillance Solution Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	3.62 billion
Growth rate	CAGR of 14.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter International Inc; Premier Inc.; Cerner Corporation; Becton; Dickinson and Company; GOJo Industries, lnc.; Sunquest; BMCorporation; OASIS Medical; Ecolab lnc.; Harris Healthcare; CenTrak, Inc.; Roper Technologies.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options